Summary miRagen Therapeutics Inc (miRagen) is a clinical stage biopharmaceutical company that offers RNA-targeting therapies to improve human health. It specializes in miRNA biology, oligonucleotide chemistry and drug development. The company’s product pipeline includes microRNA (miRNA) based therapies, MRG-201, an anti-fibrosis product candidate; and MRG-106, an anti-cancer product candidate. These product candidates are under Phase I clinical study. miRagen develops miRNA therapies for the treatment of complex diseases including neuro-inflammatory diseases, wound healing cardiovascular disease, pathological fibrosis and hematological malignancies. It has research and development collaborations with academic institutions, biotechnology and pharmaceutical companies. miRagen is headquartered in Boulder, Colorado, the US. miRagen Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized... Research Beam Model: Research Beam Product ID: 1045257 250 USD New
miRagen Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

miRagen Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : November   2016
  • Pages : 35
  • Publisher : GlobalData
 
 
 
Summary

miRagen Therapeutics Inc (miRagen) is a clinical stage biopharmaceutical company that offers RNA-targeting therapies to improve human health. It specializes in miRNA biology, oligonucleotide chemistry and drug development. The company’s product pipeline includes microRNA (miRNA) based therapies, MRG-201, an anti-fibrosis product candidate; and MRG-106, an anti-cancer product candidate. These product candidates are under Phase I clinical study. miRagen develops miRNA therapies for the treatment of complex diseases including neuro-inflammatory diseases, wound healing cardiovascular disease, pathological fibrosis and hematological malignancies. It has research and development collaborations with academic institutions, biotechnology and pharmaceutical companies. miRagen is headquartered in Boulder, Colorado, the US.

miRagen Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
miRagen Therapeutics Inc, Medical Devices Deals, 2010 to YTD 2016 9
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
miRagen Therapeutics Raises USD41 Million in Series C Financing 12
miRagen Therapeutics Raises US$20 Million In Series B Financing 14
Partnerships 16
Les Laboratoires Enters Into Co-Development Agreement With miRagen Therapeutics 16
miRagen Therapeutics Enters Research Collaboration With University of Colorado 18
Santaris Pharma Enters Into Strategic Alliance With miRagen Therapeutics 19
RXi Pharma Enters Into Research Agreement With miRagen Therapeutics 20
Merger 21
Signal Genetics to Merge with miRagen Therapeutics 21
Licensing Agreements 23
Servier and miRagen Extend Licensing Agreement for Cardiovascular Disease 23
miRagen Therapeutics Enters Into Licensing Agreement With University of Glasgow 24
Santaris Pharma Expands Licensing Agreement With miRagen Therapeutics For LNA-Drugs 26
Servier Enters into Licensing Agreement with miRagen for Cardiovascular Disease 27
miRagen Therapeutics Enters Into Licensing Agreement With t2cure 28
Equity Offering 29
miRagen Therapeutics to Raise USD40 Million in Private Placement of Shares 29
Debt Offering 31
miRagen Therapeutics Raises USD8.5 Million in Private Placement of Notes 31
miRagen Therapeutics Inc - Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables
List of Tables
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 1
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
miRagen Therapeutics Inc, Deals By Therapy Area, 2010 to YTD 2016 8
miRagen Therapeutics Inc, Medical Devices Deals, 2010 to YTD 2016 9
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
miRagen Therapeutics Raises USD41 Million in Series C Financing 12
miRagen Therapeutics Raises US$20 Million In Series B Financing 14
Les Laboratoires Enters Into Co-Development Agreement With miRagen Therapeutics 16
miRagen Therapeutics Enters Research Collaboration With University of Colorado 18
Santaris Pharma Enters Into Strategic Alliance With miRagen Therapeutics 19
RXi Pharma Enters Into Research Agreement With miRagen Therapeutics 20
Signal Genetics to Merge with miRagen Therapeutics 21
Servier and miRagen Extend Licensing Agreement for Cardiovascular Disease 23
miRagen Therapeutics Enters Into Licensing Agreement With University of Glasgow 24
Santaris Pharma Expands Licensing Agreement With miRagen Therapeutics For LNA-Drugs 26
Servier Enters into Licensing Agreement with miRagen for Cardiovascular Disease 27
miRagen Therapeutics Enters Into Licensing Agreement With t2cure 28
miRagen Therapeutics to Raise USD40 Million in Private Placement of Shares 29
miRagen Therapeutics Raises USD8.5 Million in Private Placement of Notes 31
miRagen Therapeutics Inc, Key Competitors 32
miRagen Therapeutics Inc, Key Employees 33

List Of Figures
List of Figures
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
miRagen Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
miRagen Therapeutics Inc, Medical Devices Deals, 2010 to YTD 2016 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter